Explore Innate Pharma analyst ratings and price targets (OTC:IPHYF) on Benzinga. Stay updated on expert opinions and forecasts for IPHYF stock.
There is no price target for Innate Pharma
There is no analyst for Innate Pharma
There is no last upgrade for Innate Pharma
There is no last downgrade for Innate Pharma.
There is no next analyst rating for Innate Pharma.
There is no next analyst rating for Innate Pharma.